CureVac N.V. - stock earnings
CVAC Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 24, 2024 AfterMarket | - / -0.1887000000 | - | - / 34.4 million | - |
CVAC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -51.5 million USD | 17.4 million USD |
| 2023Q2 | -73.3 million USD | 8.2 million USD |
| 2023Q1 | -140.4 million USD | 12.7 million USD |
| 2022Q4 | -138.2 million USD | 12.5 million USD |
| 2022Q3 | -46.7 million USD | 11.0 million USD |
| 2022Q2 | -60.2 million USD | 21.1 million USD |
| 2022Q1 | -2.2 million USD | 46.0 million USD |
| 2021Q4 | -2.2 million USD | 46.9 million USD |
| 2021Q3 | -166.8 million USD | 34.0 million USD |
| 2021Q2 | -180.3 million USD | 26.6 million USD |
| 2021Q1 | -67.2 million USD | 7.0 million USD |
| 2020Q4 | -69.8 million USD | 7.3 million USD |
| 2020Q3 | -43.2 million USD | 6.1 million USD |
| 2020Q2 | -11.6 million USD | 38.8 million USD |
| 2020Q1 | -26.3 million USD | 3.4 million USD |
| 2019Q4 | -40.3 million USD | 7.6 million USD |
| 2019Q3 | -20.1 million USD | 1.2 million USD |
| 2019Q1 | -23.9 million USD | 3.5 million USD |
CVAC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -334.2 million USD | 47.4 million USD |
| 2022 | -267.3 million USD | 72.4 million USD |
| 2021 | -468.2 million USD | 117.1 million USD |
| 2020 | -157.2 million USD | 59.6 million USD |
| 2019 | -111.9 million USD | 19.5 million USD |
| 2018 | -81.5 million USD | 14.7 million USD |
CVAC
Price: $2.33
52 week price:
Earnings Per Share: -1.59 USD
P/E Ratio: -2.18
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 537100
Market Capitalization: 517.3 million